Heart Failure Reviews

, Volume 16, Issue 6, pp 569–573

Arrhythmic complication in cardiorenal syndrome

  • Luigi Padeletti
  • Lisa Innocenti
  • Alessandro Paoletti Perini
  • Edoardo Gronda
Article

Abstract

In this paper, two different aspects of the relationship between chronic kidney disease and sudden cardiac death (SCD) have been reviewed. In end-stage renal disease patients, SCD risk is increased, and among patients implanted with a cardioverter defibrillator (ICD), dialysed ones carry a superior relative risk compared to non-dialysed ones. Cardiorenal syndrome patients have increase in SCD risk, and when receiving ICD implantation, survival improves.

Keywords

Sudden cardiac death End-stage renal disease Implanted cardioverter defibrillator Cardiorenal syndrome Haemodialysis Ventricular arrhythmias Glomerular filtration rate Cardiac remodelling 

References

  1. 1.
    USRDS (2007) Annual data report Bethesda, Maryland: National institute of diabetes and digestive and kidney disease, 2007Google Scholar
  2. 2.
    Cheung AK, Sarnak MJ, Yan G et al (2004) Cardiac diseases in maintenance haemodialysis patients: results of the HEMO study. Kidney Int 65:2380–2389PubMedCrossRefGoogle Scholar
  3. 3.
    Wanner C, Krane V, Marz W et al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing haemodialysis. N Engl J Med 353:238–248PubMedCrossRefGoogle Scholar
  4. 4.
    Myerburg RJ, Castellanos A (2006) Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 3:235–239PubMedCrossRefGoogle Scholar
  5. 5.
    Ramirez G, Brueggemeyer CD, Newton JL (1984) Cardiac arrhythmias in haemodialysis in chronic renal failure patients. Nephron 36:212–218PubMedCrossRefGoogle Scholar
  6. 6.
    Gruppo emodialisi patologie cardiovascolari (1988) Multicentre cross sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 2:305–308Google Scholar
  7. 7.
    Mangrum JM, Lin D, Dimarco JP (2006) Prognostic value of LV systolic function in haemodialysis patients. Heart Rhythm 3:s154CrossRefGoogle Scholar
  8. 8.
    London GM (2003) Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16(2):85–94PubMedCrossRefGoogle Scholar
  9. 9.
    Munger MA, Ateshkadi A, Cheung AK et al (2000) Cardiopulmonary events during haemodialysis: effects of dialysis membranes and dialysate buffers. Am J Kidney Dis 36:130–139PubMedCrossRefGoogle Scholar
  10. 10.
    Groos ML, Ritz E (2008) Hyperthrophy and fibrosis in the cardiomyopathy of uraemia: beyond coronary heart disease. Semin Dial 21(4):308–318CrossRefGoogle Scholar
  11. 11.
    LeWinter MM, Decena B, Tischler MD et al (2000) Abnormalities of myocardial relaxation and filling: diastolic dysfunction. In: Hosenpud JD, Greenberg BH (eds) Congestive heart failure, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 94–98Google Scholar
  12. 12.
    Keung EC (1989) Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ. Res 64:753–763Google Scholar
  13. 13.
    Zaza A (2009) Serum potassium and arrhythmias. Europace 11:421–422PubMedCrossRefGoogle Scholar
  14. 14.
    Karnik JA, Young BS, Lew NL et al (2001) Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350–357PubMedCrossRefGoogle Scholar
  15. 15.
    Bleyer AJ, Hartman J, Brannon PC et al (2006) Characteristic of sudden death in haemodialysis patients. Kidney Int 69:2268–2273PubMedCrossRefGoogle Scholar
  16. 16.
    Schwartz PJ, Priori SG, Napolitano C (2000) The long QT syndrome. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology. From cell to bedside, 3rd edn. WB Sauders Company, Philadelphia, PA, pp 597–615Google Scholar
  17. 17.
    Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883PubMedCrossRefGoogle Scholar
  18. 18.
    Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 252:225–237CrossRefGoogle Scholar
  19. 19.
    Herzog CA, Li S, Weinhandl ED et al (2005) Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68:818–825PubMedCrossRefGoogle Scholar
  20. 20.
    Sakhuja R, Keebler M, Lai TS et al (2009) Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 103:735–741PubMedCrossRefGoogle Scholar
  21. 21.
    Ronco C, Happio M, House A et al (2008) Cardiorenal sindrome. J Am Coll Cardiol 52:1527–1539PubMedCrossRefGoogle Scholar
  22. 22.
    Jessupp M, Costanzo MR (2009) The cardiorenal syndrome. J Am Coll Cardiol 53(7):582–598CrossRefGoogle Scholar
  23. 23.
    Go AS, Chertow GM, Fan Dongjie MPH et al (2004) Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRefGoogle Scholar
  24. 24.
    Iguchi Y, Kimura K, Kobayashi K et al (2008) Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 102:1056–1059PubMedCrossRefGoogle Scholar
  25. 25.
    Watanabe H, Watanabe T, Sasaki S et al (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158:629–636PubMedCrossRefGoogle Scholar
  26. 26.
    Manjunath G, Tighouart H, Hibrahim H et al (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the community. J Am Coll Cardiol 41(1):47–55PubMedCrossRefGoogle Scholar
  27. 27.
    Goldenberg I, Moss AJ, Mcnitt S et al (2006) Relations among renal function, risk of sudden cardiac death and benefit of the implanted cardiac defibrillator in patients with ischemic LV dysfunction. Am J Cardiol 98:485–490PubMedCrossRefGoogle Scholar
  28. 28.
    Saxon LA, Bristow MR, Bohemer J et al (2006) Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION). Circulation 114:2766–2772PubMedCrossRefGoogle Scholar
  29. 29.
    Deo R, Lijn F, Vittinghoff E et al (2008) Kidney dysfunction and sudden cardiac death among women with coronary artery disease. Hypertension 51:1578–1582PubMedCrossRefGoogle Scholar
  30. 30.
    The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhytmic drug therapy with ICD in patients resuscitated from near fatal ventricular arrhytmia. N Engl J Med 337:1576–1583CrossRefGoogle Scholar
  31. 31.
    Hreybe H, Ezzeddine R, Bedi M et al (2006) Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 151:852–856PubMedCrossRefGoogle Scholar
  32. 32.
    Takahashi A, Shiga T, Shoda M et al (2009) Impact of renal dysfunction on appropriate therapy in ICD patients with non ischemic dilated cardiomyopathy. Europace 1(11):1476–1482CrossRefGoogle Scholar
  33. 33.
    Cuculich PS, Sanchez JM, Kerzner R et al (2007) Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30:207–213PubMedCrossRefGoogle Scholar
  34. 34.
    Wase A, Basit A, Nazir R et al (2004) Impact of chronic kidney disease among ICD recipients. J Interv Card Electrophys 11:199–204CrossRefGoogle Scholar
  35. 35.
    Amin MS, Fox AD, Kalahasty G et al (2008) Benefit of primary prevention implantable cardioverter defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 19:1275–1280PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Luigi Padeletti
    • 1
  • Lisa Innocenti
    • 1
  • Alessandro Paoletti Perini
    • 1
  • Edoardo Gronda
    • 2
  1. 1.Istituto di Clinica Medica e CardiologiaUniversità degli Studi di FirenzeFlorenceItaly
  2. 2.FESC Gruppo MultimedicaIRCCS Sesto San GiovanniMilanItaly

Personalised recommendations